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Abstract
The ability to induce the reprogramming of somatic mammalian cells to a pluripotent state by the forced expression of
specific transcription factors has helped redefine the rules of cell fate and plasticity, as well as open possibilities for disease
modeling, drug screening and regenerative medicine. Here, we hypothesized that the non-viral forced expression of the
four originally discovered defined factors (OKSM) in adult mice could result in in vivo reprogramming of cells in the
transfected tissue in situ. We show that a single hydrodynamic tail-vein (HTV) injection of two plasmids encoding for Oct3/4,
Sox2, Klf4 and c-Myc respectively, are highly expressed in the liver tissue of Balb/C adult mice. Hallmark pluripotency markers
were upregulated within 24–48 h after injection, followed by down-regulation of all major hepatocellular markers.
Generation of transcriptionally reprogrammed cells in vivo was further confirmed by positive staining of liver tissue sections
for all major pluripotency markers in Balb/C mice and the Nanog-GFP reporter transgenic strain (TNG-A) with concomitant
upregulation of GFP expression in situ. No signs of physiological or anatomical abnormalities or teratoma formation were
observed in the liver examined up to 120 days. These findings indicate that virus-free expression of OKSM factors in vivo can
transcriptionally reprogram cells in situ rapidly, efficiently and transiently, absent of host tissue damage or teratoma
formation.
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Introduction
Forced reprogramming of somatic cells into a pluripotent, stem
cell-like state by the ectopic expression of specific transcription
factors results in the generation of induced pluripotent stem (iPS)
cells. Such transcription factor cell reprogramming has been
achieved today by viral [1,2,3] and non-viral [4,5,6,7] gene
transfer, protein cytoplasmic translocation [8,9], miRNA [10] and
is changing the landscape in developmental biology, can
potentially resolve all ethical concerns about the use of embryonic
stem cells and open further opportunities for regenerative
medicine. The original discovery by Yamanaka and colleagues
that the in vitro expression of four transcription factors, Oct3/4,
Klf4, Sox2, c-Myc (OKSM) was capable to revert fully differen-
tiated mouse and human skin fibroblasts into iPS cells [1,11]
constitutes the most widely used transcription-based reprogram-
ming technology today.
The initial reports of transcription-mediated somatic cell
reprogramming involved the use of retroviruses to stably transduce
skin fibroblasts with defined transcription factors [1,2,11]. This
methodology of gene transfer is still today the most popular way to
reprogram animal and human somatic cells despite the risks from
insertional mutagenesis, stable transduction and long-term gene
expression of known proto-oncogenes [12,13]. Moreover, the vast
majority of current methodologies to generate iPS cells involve use
of long-term culture conditions and treatment of cells with
multiple rounds of gene transfer vectors, growth factors, antibiotics
and other cell media cocktails to promote reprogramming and
select for pluripotency. All of these are considered major culprits
for the potential risks associated with the ensuing cells as recent
studies investigating the genomic integrity of iPS have alluded to
[14,15,16]. In terms of iPS generation using non-viral gene
transfer vectors, plasmid DNA [4,5,6] or RNA [7,10] delivery
using liposomes or electroporation have been reported. Compared
to viruses, episomal vectors are generally considered safer,
however transduction and reprogramming efficiencies are much
lower [13]. Alternatively, Warren et al. reported somatic cell
reprogramming in vitro by direct delivery of synthetic mRNAs [7].
Although this methodology offers significantly higher reprogram-
ming efficiency, high RNA dosages, multiple rounds of trans-
fection and complex cell culturing protocols are still needed [13].
Due to the paradigm-shifting nature of transcription-induced
reprogramming to pluripotency there is still limited understanding
of the exact mechanisms and pathways implicated in induced cell
reprogramming, and the exact features of reprogrammed cells
[17,18]. Morever, the majority of experimental evidence today is
based on the concept of extraction and in vitro manipulation of the
somatic cells to be reprogrammed, leading to the array of caveats
mentioned above that make clinical translation of iPS cells seem
distant [19,20,21]. In the present work, we hypothesized that
in vivo forced expression of the OKSM transcription factors by
non-viral transient over-expression within living tissue can induce
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cell reprogramming towards pluripotency. In order to test this
hypothesis we chose the most naive, non-viral gene transfer
technology available today: large-volume, rapid hydrodynamic tail
vein (HTV) injection of plasmid DNA [22,23] encoding the
originally proposed OKSM factors. This gene transfer methodol-
ogy circumvents most complications or risks associated with viral
gene transfer vectors, as has been previously shown in numerous
preclinical [24,25] and clinical [26,27] studies allowing un-
precedented levels of exogenous gene expression in hepatocytes.
Methods
Plasmids
Reprogramming plasmids pCX-OKS-2A encoding OCT3/4,
KLF4, SOX2; pCX-cMyc encoding CMYC and pCAG-GFP
encoding eGFP under the control of CAG promoter (as previously
described by Okita et al. [4]) were obtained from Addgene (USA)
as bacterial stabs. Research grade plasmid production was
performed from these stabs (Plasmid Factory, Germany). pGFP-
Luc plasmid (Clontech, USA) encodes for the eGFP and Luc
transgenes under the control of a CMV promoter. Vector maps of
all plasmids used in this work are included in Figure S5.
Animals and Hydrodynamic Tail Vein (HTV) Injection of
Plasmids
All experiments were performed with prior approval from the
UK Home Office under a Home Office project license (PPL 80/
2296). Female Balb/C mice, 6 weeks old were purchased from
Harlan, UK. TNG-A mice which carry the eGFP reporter
inserted into the Nanog locus [28], were a kind gift from The
Wellcome Trust Centre for Stem Cell Research, University of
Cambridge, UK. TNG-A mice and WT controls, were of 129
background and were bred and genotyped at the UCL. Mice were
allowed one week to acclimatize prior to use. Mice (4 animals/
group)were warmed in a 37uC heating chamber, anesthetized with
isofluorane and were injected via tail vein in 5–7 sec with 1.5 ml of
0.9% saline including 75 mg of pCX-OKS-2A with and without
75 mg of pCX-cMyc or 150 mg pCAG-GFP plasmids or no
plasmid. Mice were culled at different time points, such as 2, 4, 8,
12, 24, 50, 120 days after HTV injections.
Isolation of Hepatocyte Population
Mice livers were perfused as previously described [36] with
some modifications. In brief, livers were first perfused with Ca2+
and Mg2+ free Hank’s buffered salt solution (Sigma-Aldrich, UK)
and then with liver digest medium (Gibco, UK) at 37uC. After
digestion, liver was washed with Hepatocyte Wash Medium
Figure 1. In vivo overexpression of OKSM transcription factors in adult mouse liver. Balb/C mice were HTV injected with 0.9% saline alone,
75 mg of pCX-OKS-2A and 75 mg pCX-cMyc in 0.9% saline and at days 2, 4, 8, 12, 24, RT-qPCR analysis of hepatocytes was performed to determine the
relative gene expression of: (a) transfected transcription factors (OKSM) and (b) endogenous pluripotency markers. All gene expression levels were
normalized to HTV-injected saline group (*p,0.05 indicates statistically significant differences between the expression levels of pluripotency markers
in the OKSM and saline HTV-injected groups, obtained by the analysis of variance and Tukey’s pairwise comparison); (c) flow cytometry analysis of
OCT3/4 positive and NANOG positive cells in liver extracts; (d) relative gene expression of hepatocyte markers as determined by RT-qPCR. All gene
expression levels were normalized to saline HTV-injected group (* p,0.05 indicates statistically significant differences between the expression levels
for hepatocyte markers in the OKSM and saline HTV-injected groups, obtained by the analysis of variance and Tukey’s pairwise comparison).
doi:10.1371/journal.pone.0054754.g001
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(HWM, Gibco, UK) and cell suspension was passed through
a 100 ml cell strainer (VWR, UK) at 4uC. Cells were centrifuged at
50 g for 5 min to separate parenchymal cells (PC including
hepatocytes) which were collected in pellet and non-parenchymal
cells (NPC including Kupffer cells and epithelial cells) which stayed
in supernatant. The hepatocyte fraction was collected after
washing twice with HWM.
RNA Isolation and Reverse Transcription-quantitative PCR
(RT-qPCR) Analysis
Following liver perfusion and isolation of hepatocytes, RNeasy
Blood and Tissue Kit (Qiagen, UK) were used to isolate total
RNA. cDNA synthesis from 1 mg of RNA sample was performed
by iScript cDNA synthesis kit (Bio-Rad, UK) according to
manufacturer’s instructions. Two microliters of each cDNA
sample was used to perform RT-qPCR reactions with iO SYBR
Green Supermix (Bio-Rad, UK). Primer sequences are shown in
Table S1. Samples were run on CFX-96 Real Time System (Bio-
Rad, UK) with the following protocol: 95uC for 3 min, 1 cycle;
95uC for 10 sec, 60uC for 30 sec, – repeated for 40 cycles. b-actin
was used as a housekeeping gene and gene expression levels were
normalized to saline groups.
Flow Cytometry
Cell density was adjusted to 16107 cells/ml and 100 ml
suspensions were aliquoted in microfuge tubes. BD Mouse
Pluripotent Stem Cell Transcription Factor Analysis Kit (BD
Biosciences, UK) were used to analyze OCT3/4-positive or
NANOG-positive cells. In brief, cells were firstly fixed with BD
Cytofix fixation buffer and permeabilized with 1X BD Perm/
Wash buffer. Then cells were incubated with either anti-mouse
OCT4-PerCP-Cy5.5 or anti-mouse NANOG-PE for 30 min
according to manufacturer’s instructions. Negative and isotype
controls were included in each experiment. Stained cells were then
analyzed by CyAnTM ADP High-Performance Research Flow
Figure 2. OKSM and OKS factor overexpression with dose-response in adult mouse liver. Balb/C mice HTV injected with 0.9% saline
alone, pCX-OKS-2A with (OSKM) and without (OKS) pCX-cMyc in 0.9% saline, or pCAG-GFP in 0.9% saline, at the indicated doses. On day 4, RT-qPCR
analysis of hepatocyte extracts was performed. (a) Expression levels of the injected reprogramming transcription factors and endogenous
pluripotency genes were determined for plasmid dose-escalation (total plasmid dose 50, 75 and 100 mg/animal). All gene expression levels were
normalized to the HTV-injected saline group (*p,0.05 indicates statistically significant differences between the expression levels of pluripotency
markers in the OKSM and saline HTV-injected groups, obtained by the analysis of variance and Tukey’s pairwise comparison); (b) Expression levels of
the injected reprogramming transcription factors and endogenous pluripotency genes with and without inclusion of cMyc. All gene expression levels
were normalized to HTV-injected saline group (**p,0.01 indicates statistically significant differences between the expression levels of pluripotency
markers in the OKSM and OKS injected groups, obtained by the analysis of variance and Tukey’s pairwise comparison).
doi:10.1371/journal.pone.0054754.g002
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Cytometer (DakoCytomation, USA) at the Institute of Child
Health, University College London, UK.
Quantification of Serum Cytokine Levels
Blood was collected from mice at different time points. Serum
levels of ALT, AST, ALP, GLDH were determined by Diagnostic
Laboratories in the Royal Veterinary College, London, UK.
Immuno-histochemistry (IHC) of Mouse Livers
Livers were perfused with 10 mL HBSS, pre-warmed at 37uC,
then immediately immersed into isopentane, pre-cooled in liquid
nitrogen or into stabilized 4% paraformaldehyde for fixation.
Frozen livers were stored at 280uC until further processing.
Fourteen micron thick sections were prepared on a Cryomicro-
tome (Leica Microsystems, CM3050S), air-dried for 1hour at
room temperature, before storage at 220uC. Before staining, liver
sections were post-fixed with methanol, pre-cooled at 220uC, for
10 min at 220uC, then air-dried for 15 min and finally washed
twice with PBS for 5 min. For Oct4, Sox2 and Nanog, we used
a conventional immunostaining protocol that consisted of 1 h
incubation in blocking buffer (5% goat serum-0.1% Triton in PBS
pH 7.3) at room temperature, followed by two washing steps with
PBS (1%BSA- 0.1% Triton, pH 7.3) before overnight incubation
at +4uC with the different primary antibodies [(rabbit pAb anti-
OCT4 (ab19857,3 mg/ml, Abcam, UK)/rabbit pAb anti-SOX2
(ab97959, 1 mg/ml, Abcam, UK)/rabbit polyclonal anti-NANOG
(ab80892, 1 mg/ml, Abcam, UK]). Next day sections were washed
(2 min each) with PBS and incubated (1.5 hours at room
temperature) with the secondary antibody (goat polyclonal anti-
Figure 3. In vivo cell reprogramming on adult mouse liver tissue by immunohistochemistry. Balb/C mice HTV injected with 0.9% saline
alone, 75 mg of pCX-OKS-2A and 75 mg pCX-cMyc in 0.9% saline, or 150 mg of pCAG-GFP in 0.9% saline and at day 4, livers were collected and frozen
tissue sections were stained with anti-OCT4, anti-SOX2 or anti-NANOG antibodies to assess immunoreactivity, or BCIP/NBT to determine ALP activity
in the tissue (40x). Scale bars represent 100 mm.
doi:10.1371/journal.pone.0054754.g003
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rabbit IgG labeled with Cy3, 1/250, Jackson ImmunoResearch
Laboratories Inc.). For SSEA1 immunostain, a mouse monoclonal
antibody (ab16285, 20 mg/ml, Abcam,UK) was used, which make
it more suitable to use a specific immunodetection kit to localize
mouse antibodies on mouse tissues (vector MOM immunodection
kit, Vector Laboratories). The endogenous liver avidin/biotin
were blocked with Avidin/blocking Kit (Vector Laboratories,
UK). The staining procedure was performed according to the
supplier recommendations, using either the provided secondary
biotinylated anti-mouse IgG revealed by fluorescein-tagged Avidin
(1/250, Vector Laboratories) or a goat polyclonal anti-mouse IgG
labeled with Cy3 (1/250, Jackson ImmunoResearch Laboratories
Inc.). Then liver sections were washed with PBS and mounted in
DAPI and antifade containing medium (Vectashield mounting
medium, Vector Laboratories, UK). Slides were visualised under
epi-fluorescence microscope (Zeiss Axio Observer). Paraformalde-
hyde fixed samples were paraffin-embedded and liver sections
were stained with Haematoxylin and Eosin (H&E) by Diagnostic
Laboratories in the Royal Veterinary College, London, UK.
Random images were captured by light microscopy for different
treatment groups.
Periodic Acid Schiff (PAS) Staining of Liver Sections
Liver samples were fixed in paraformaldehyde, paraffin-
embedded and liver sections were stained with PAS stain (Sigma,
UK). Random images were captured by light microscopy for saline
or OKSM treatment groups.
Alkaline Phosphatase (ALP) Staining of Cell Cultures and
Liver Sections
ALP activity staining was performed using the BCIP/NBT
liquid substrate system (Sigma UK). Methanol-fixed cell cultures
were first washed with HEPES buffer and then incubated at 37uC
for 30 min with the BCIP/NBT liquid substrate system. Color
development was stopped by rinsing with water. In order to
determine ALP activity in the tissue, frozen liver sections were
prepared as described above and incubated with BCIP/NBT
liquid substrate system for 30 min. Sections were washed with
water and mounted. Random images were captured by light
microscopy (106) for saline, GFP or OKSM treatment groups.
Statistical Analysis
Experiments were performed with at least four animals per
group. Statistical analysis was performed by analysis of variance
and Tukey’s pairwise comparison using SPSS software, version
16.0.
Results
Mice were injected by HTV with an equimolar mix of two
plasmids, pCX-OKS-2A and pCX-cMyc, encoding for the OKS
and M reprogramming factors respectively. HTV injection of
plasmid DNA has been known to result in high levels of gene
expression in hepatocytes [22,23] and primary hepatocytes from
OKSM-injected animals were extracted at different time points
here. RT-qPCR and flow cytometry were used to analyze the
expression levels for various reprogramming (Oct3/4, Sox2, c-Myc),
pluripotency (Nanog, Ecat1, Rex1, Cripto, Gdf3 and endogenous
Oct3/4, Klf,4 or Sox2) and hepatocyte markers (Alb, Trf, Aat)
directly after extraction of the hepatocytes at different time points
after HTV injection.
A significant increase in the gene expression of all transduced
transcription factors was observed on day 2 that decreased over
time (Figure 1a). At the same time endogenous pluripotency
markers were upregulated, reached peak values on day 4 and
decreased to background levels from day 8 onward (Figure 1b).
Protein expression in the hepatocyte extracts from the transduced
Figure 4. In vivo cell reprogramming in TNG-A mice. TNG-A mice were HTV injected with 0.9% saline alone, 75 mg of pCX-OKS-2A and 75 mg
pCX-cMyc in 0.9% saline and at days 2, 4, RT-qPCR analysis of hepatocytes was performed to determine the relative gene expression of: (a)
transfected transcription factors (OKSM) and (b) endogenous pluripotency markers. All gene expression levels were normalized to HTV-injected saline
group (*p,0.05 indicates statistically significant differences between the expression levels of pluripotency markers in the OKSM and saline HTV-
injected groups, obtained by the analysis of variance and Tukey’s pairwise comparison); (c) flow cytometry analysis of GFP positive cells in liver
extracts; (d) liver tissue frozen and sectioned to image GFP-positive cells with fluorescence microscopy at day 4 (10x).
doi:10.1371/journal.pone.0054754.g004
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liver tissue using flow cytometry indicated that on day 1 only
OCT3/4 was expressed, whereas by day 4 both OCT3/4 and
NANOG positive cells were detected (Figure 1c). Examination of
the expression levels of hepatocyte markers by RT-qPCR
indicated that on day 2 they were similar to those of animals
HTV injected with saline, while on day 4 significant down-
regulation in hepatocyte marker expression was considered as
another indication of cell reprogramming, manifested by the de-
differentiation of hepatocytes (Figure 1d). Later than day 8,
hepatocyte markers returned back to control levels, while on day
24 increased levels of these markers were obtained.
Transgene expression by HTV injection was monitored
separately by injection of control plasmids encoding for GFP-
luciferase (pCMV-GFP-luc) and eGFP (pCAG-eGFP). Figure S1
confirms that hepatocytes were the targeted cell population in the
liver following HTV injection as previously reported. The kinetics
of transgene expression in the liver following HTV injection with
the OKSM plasmids indicated that from day 9 onward,
pluripotency factors began to be down-regulated reaching naive
levels by day 22 (Figure S2). The effect of plasmid dose was then
studied by HTV injections of OKSM against control (pCAG-
eGFP) plasmid DNA at an escalated dose regime (Figure 2a). A
sharp increase in the levels of gene expression profile of the
transduced reprogramming and other endogenous pluripotent
factors on day 4 after administration was observed only in the case
of OKSM plasmid DNA injections, and the levels of up-regulation
reached a plateau at 75 mg/animal. c-Myc is a known oncogene
and its use in cell reprogramming (in particular for in vivo
strategies) is preferable to be avoided. However, a decrease in
the efficiency of reprogramming has been previously described in
the absence of this factor [30]. The effect of the presence or
absence of c-Myc in the reprogramming cocktail was also
investigated in the present study (Figure 2b). In vivo cell
reprogramming could be achieved without c-Myc, however the
levels of pluripotency markers Nanog and Ecat1 observed were
significantly lower compared to use of the OKSM cocktail, in line
with the previous reports omitting c-Myc from in vitro cell
reprogramming.
To further interrogate the occurrence of in vivo induced cell
reprogramming in the liver by the forced expression of the OKSM
transcription factors, tissue sections from transfected Balb/C mice
were directly stained immunohistochemically (IHC) at day 4 (post-
Figure 5. The effect of in vivo cell reprogramming on hepatotoxicity and liver damage. Balb/C mice HTV injected with either 75 mg of pCX-
OKS-2A and 75 mg pCX-cMyc in 0.9% saline or 0.9% saline only. On days 2, 4, 8, 12, 50 and 120 livers and sera were isolated. (a) H&E staining of liver
sections; (b) levels of liver enzymes and (c) albumin were analyzed; (d) liver sections were PAS stained to determine glycogen storage levels.
Representative images were captured with light microscopy (10x). Scale bars represent 100 mm.
doi:10.1371/journal.pone.0054754.g005
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HTV) for different pluripotency markers (Oct3/4, Sox2, Nanog
and ALP). Figure 3 shows that distinctive IHC-positive cells were
obtained for all four markers only in the case of animals injected
with the OKSM plasmids compared to saline or GFP plasmid
HTV-injected groups. Positive staining for Nanog was obtained
reproducibly in all liver sections in all OKSM-transfected animals
indicating the presence of transcriptionally reprogrammed cells
throughout the liver tissue (Figure S3). Considering the critical
role of Nanog in the control of pluripotency, we performed
a separate experiment using the transgenic strain TNG-A that
carries the eGFP reporter inserted into the Nanog locus [28].
HTV injection of the OKSM plasmids in TNG-A mice showed
enhanced gene expression in both reprogramming and endoge-
nous pluripotency markers on days 2 and 4 post-injection
(Figure 4a & b). Hepatocyte extracts from OKSM injected
TNG-A mice on day 4 were analyzed by flow cytometry for eGFP
protein expression, revealing that 6–15% of the total cell
population were eGFP positive (Figure 4c). Lastly, further
confirmation of the generation of reprogrammed cells in the liver
was offered by the presence of eGFP-positive cells in frozen tissue
sections imaged by fluorescence microscopy (Figure 4d).
One of the key concerns by induction of reprogramming
towards pluripotency in vivo may be the spontaneous occurrence of
teratomas within the tissues where reprogrammed cells are
generated [12,19]. To address this, animals HTV-injected with
the reprogramming factors were kept for a period of 120 days and
at frequent intervals (days 2, 4, 8, 12, 50 and 120) different groups
were analyzed heamatologically and histologically (Figure 5a).
HTV injection of plasmid DNA can result in moderate tissue
damage manifested by increased serum levels of liver enzymes at
early time points [26], which was also observed here at day 2 for
both saline and OKSM injected groups (Figure 5a & S4). H&E
staining of liver tissues indicated that HTV injection of OKSM
plasmids did not lead to any tissue damage beyond day 2, nor
development of teratomas at later time points, with all liver
sections and animals exhibiting healthy structural morphology and
behavior with no signs of dysplasia (Figure 5a). Serum levels were
also analyzed for liver enzymes over the same period, with no
aberrant change in the levels of ALT, AST and GLDH between
the saline-injected and OKSM-injected groups (Figure 5b).
Albumin levels and glycogen staining of liver sections (Figure 5c
& d) further confirmed no hepatic structural or functional
abnormality throughout the course of the study for any of the
animals. These findings in conjunction with the gene and protein
expression analyses of the liver tissue (Figure 1) suggested that
transcriptional cell reprogramming was occurring in vivo rapidly
after HTV-injection of the OKSM factors, similar to recent direct
reprogramming (transdifferentiation) studies [29,30,31]. We spec-
ulate that the endogenous tissue milieu (growth factors, homeo-
static signaling cues) leads to rapid loss of the transcriptionally
reprogrammed cells into phenotypically normal, functioning
hepatocytes. However, much more work using lineage-tracing
techniques is needed to elucidate the mechanisms and extent of
in vivo cell reprogramming to a pluripotent state.
Discussion
This study provides previously unreported evidence that direct
in vivo transcriptional cell reprogramming towards the pluripotent
state in adult mammalian somatic (hepatocyte) cells is possible
using non-viral transfection of plasmids encoding the OKSM (or
OKS) transcription factors. This occurs following rapid kinetics
(within 24–48 h) that are, in principle, reminiscent of the kinetics
described for somatic cell reprogramming using the egg and
oocyte nuclear transfer methodologies [32]. Zhou et al. have
previously reported rapid and highly efficient in vivo conversion of
pancreatic exocrine cells directly into insulin secreting b-cells
without reverting to a pluripotent state (i.e. by transdifferentiation)
using adenovirus-mediated transcription factor (not OKSM)
overexpression [33]. Very recently, three studies have also offered
proof-of-concept evidence that transcriptionally-induced, direct
transdifferentiation from fibroblasts to cardiomyocyte-like cells in
infracted heart tissue in situ can offer therapeutic benefits
[29,30,31]. In all such previous work direct conversion to different
lineages is reported without reprogramming towards a plutipotent
state, shown to take place rapidly and efficiently (compared to
in vitro transdifferentiation methodologies). From our studies
herein, in vivo cell reprogramming by overexpression of OKSM
transcription factors is also shown to be rapid and efficient enough
to be detected in situ, however transiently maintained. According
to our semi-quantitative analysis based on FACS and IHC of liver
sections from transfected Balb/C and TNG-A mice, it took place
efficiently in the order of 5–15% of the total hepatocyte
population. Even though upregulation of eGFP and pluripotency
markers in the TNG-A mice strongly suggest that HTV injection
of OKSM plasmids can result in adult somatic cell reprogramming
toward pluripotency in vivo, further studies are needed to de-
termine the level of pluripotency achieved, similar to previous
Nanog-activity studies using ES cells [34], as well as more detailed
characterization of the extracted reprogrammed cells in relation to
the loss of hepatocyte phenotype. Moreover, the in vivo cell
reprogramming towards pluripotency in fully developed mammals
shown here is also in agreement with recently reported cell
reprogramming for non-mammalian tissue [35] and did not lead
to any structural or functional side effects in the liver, nor did it
lead to any manifestation of carcinogenesis or teratoma formation.
Further progress from this work will be the isolation and
characterization of the transcriptionally reprogrammed cells from
the primary hepatocyte extracts. Determination of the quality and
level of functional pluripotent capacity of those cells, their genomic
stability and epigenetic character, along with all the comparative
studies currently undertaken by numerous laboratories to define
the similarities and differences between iPS and ES cells will be
needed. Also, the mechanistic basis of direct in vivo induced
reprogramming of somatic cells to a pluripotent state and the
dissection of the reasons behind the rapid kinetics observed, the
extent and possible implications of transient cell reprogramming to
ground-state pluripotency that could possibly take place transiently
in situ, and the mechanisms by which the tissue microenvironment
drives rapid re-differentiation in the host cells will have to be
determined.
Enhancement of the level of in vivo cell reprogramming to
a pluripotent state can also be envisaged by improvements in gene
transfer methodology, dosing regimen and vector construct design.
Finally, it can be envisioned that improved (and less invasive)
protocols and technologies for the possible generation of in vivo
induced pluripotent cells may lead to a general methodology for
the extraction of autologous cells from tissue (liver or other) rapidly
and with minimization of risks (mutagenesis, media contamina-
tion, xenobiotic reagents, etc) from culturing conditions and
protocols. Overall, this study offers the basis of a rapid, virus-free,
efficient, and in the absence of culturing complications in vivo
platform to study reprogramming mechanisms in situ using adult,
fully developed, somatic tissue.
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Supporting Information
Figure S1 Transfection after HTV injection. Balb/C mice were
HTV injected with pCMV?GFP-Luc in 0.9% saline and
hepatocytes were isolated after 24 h and analyzed for (a) luciferase
activity by luciferase assay (b) GFP and Luc gene expression by
real-time PCR. Balb/C mice were HTV injected with
pCAG?GFP in 0.9% saline and hepatocytes were isolated after
24 h and analyzed for (c) eGFP gene expression by real-time PCR
(d) transfection efficiency by FACS. (e) Liver samples were frozen
and sectioned to image transfected hepatocytes under (i)
differential interference contrast (DIC) illumination or (ii) blue
light excitation (10x).
(TIF)
Figure S2 Flow cytometry analysis of in vivo-reprogrammed
hepatocyte extracts. Balb/C mice HTV injected with 0.9% saline
alone, 75 mg of pCX-OKS-2A and 75 mg pCX-cMyc in 0.9%
saline, or 150 mg of pCAG-GFP in 0.9% saline. On days 1, 4, 9,
11 and 22, hepatocytes were isolated and stained for OCT3/4,
SOX2 and NANOG.
(TIF)
Figure S3 NANOG immunofluorescence staining of different
liver sections after HTV injection of reprogramming plasmids.
Balb/C mice HTV injected with 75 mg of pCX-OKS-2A and
75 mg pCX-cMyc in 0.9% saline. On day 4, liver tissue was
collected and frozen tissue sections were immunostained with an
anti-NANOG antibody. Scale bars represent 100 mm.
(TIF)
Figure S4 The effect of HTV injection of plasmids on liver
damage at early time points. Balb/C mice HTV injected with
either 75 mg of pCX-OKS-2A and 75 mg pCX-cMyc in 0.9%
saline or 0.9% saline only. On days 2, 4, 8, 12 sera were isolated
and analyzed for the levels of liver enzymes.
(TIF)
Figure S5 Plasmid DNA maps used in this study. (a) pCX-
OKS-2A, (b) pCX-c-Myc, (c) pCAG-GFP and (d) pGFP-Luc
plasmids.
(TIF)
Table S1 Primer seqeunces used in this study.
(TIF)
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